Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 33.2B | 33.2B | 38.5B | 34.5B |
Cost of revenue | 27.7B | 26.7B | 31.0B | 28.3B |
Gross profit | 5.4B | 6.6B | 7.4B | 6.2B |
Operating expense | ||||
Research & development | 1.5B | 1.6B | 969M | 1.7B |
Selling general and admin | 3.1B | 3.1B | 3.6B | 2.8B |
Other operating expenses | 255M | 70M | 47M | 72M |
Operating income | 988M | 2.2B | 3.2B | 2.1B |
Non operating interest income | ||||
Income | 156M | 180M | 188M | 165M |
Expense | 115M | 118M | 153M | 236M |
Other income expense | — | — | — | — |
Pretax income | 1.4B | 2.4B | 3.3B | 2.6B |
Tax provision | 445M | 691M | 704M | 926M |
Net income | 957M | 1.7B | 2.6B | 1.7B |
Basic EPS | 1.0 | 1.7 | — | 1.8 |
Diluted EPS | 1.0 | 1.7 | — | 1.8 |
Basic average shares | 963.2M | 962.9M | — | 1.0B |
Diluted average shares | 963.2M | 962.9M | — | 1.0B |
EBITDA | 3.1B | 4.6B | 5.3B | 4.5B |
Net income from continuing op. | 1.4B | 2.4B | 3.3B | 2.6B |
Minority interests | -42M | -53M | -119M | 14M |
Preferred stock dividends | 0 | 0 | 0 | 0 |